NASH

1 stories about NASH
נאסד"ק וול סטריט

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering

04.04.18|Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1